← Leaderboards
Melinda A Borrello
Vaccinex, Inc.
$1,486,484
Attributed
$1,486,484
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,486,484 · 3
By mechanism
R44$908,660 · 1
R43$577,824 · 2
Top collaborators
No co-investigators on record.
Most similar at Vaccinex, Inc.
Same institution · by research overlap
- Ernest S Smith$2,058,412
- Mark J Paris$1,064,755
- Maurice Zauderer$433,400
Others in their field
Top investigators on “Human Tissue”
- David Heimbrook · Leidos Biomedical Research, Inc.$294,443,261
- Lawrence Corey · Fred Hutchinson Cancer Center$212,638,156
- Larry Arthur$131,303,476
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$114,079,276
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
Research focus
Human TissueNeoplasm /Cancer VaccineCell LineVaccine DevelopmentTumor AntigensCytotoxic T LymphocyteLaboratory MouseComplementary DnaGenetically Modified AnimalsNeoplasm /Cancer GeneticsBladder NeoplasmVector VaccineGene ExpressionVaccinia VirusNeoplastic CellProstate NeoplasmsScid MouseUrinary Bladder EpitheliumXenotransplantationBiological Signal TransductionDifferential Display TechniqueEnzyme Linked Immunosorbent AssayGenetic LibraryHelper T Lymphocyte
Grant awards (5)
C35: A Target for Bladder and Breast Cancer Therapy$436,055
R44 · FY2002 · CA
C35: A Target for Bladder and Breast Cancer Therapy$472,605
R44 · FY2001 · CA
NEW TARGET ANTIGENS FOR PROSTATE CANCER VACCINES$238,912
R43 · FY2001 · CA
NEW TARGET ANTIGENS FOR PROSTATE CANCER VACCINES$238,912
R43 · FY2000 · CA
GENE EXPRESSION AND IMMUNOGENS OF UROEPITHELIAL TUMORS$100,000
R43 · FY2000 · CA